Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bax N. D., Tucker G. T., Woods H. F. Lignocaine and indocyanine green kinetics in patients following myocardial infarction. Br J Clin Pharmacol. 1980 Oct;10(4):353–361. doi: 10.1111/j.1365-2125.1980.tb01771.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Conrad K. A., Nyman D. W. Effects of metoprolol and propranolol on theophylline elimination. Clin Pharmacol Ther. 1980 Oct;28(4):463–467. doi: 10.1038/clpt.1980.189. [DOI] [PubMed] [Google Scholar]
- Facino R. M., Lanzani R. Interaction of a series of beta-adrenergic blocking drugs with rat hepatic microsomal monooxygenase. Pharmacol Res Commun. 1979 May;11(5):433–445. doi: 10.1016/s0031-6989(79)80007-7. [DOI] [PubMed] [Google Scholar]
- Greenblatt D. J., Franke K., Huffman D. H. Impairment of antipyrine clearance in humans by propranolol. Circulation. 1978 Jun;57(6):1161–1164. doi: 10.1161/01.cir.57.6.1161. [DOI] [PubMed] [Google Scholar]
- Jack D. B. Is there a relationship between the physical properties and cardioselectivity of beta-adrenoceptor antagonists? Br J Clin Pharmacol. 1981 Apr;11(4):402–406. doi: 10.1111/j.1365-2125.1981.tb01145.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Johnsson G., Regårdh C. G., Sölvell L. Lack of biological interaction of alprenolol and salicylate in man. Eur J Clin Pharmacol. 1973 Jun;6(1):9–14. doi: 10.1007/BF00561794. [DOI] [PubMed] [Google Scholar]
- Keenaghan J. B., Boyes R. N. The tissue distribution, metabolism and excretion of lidocaine in rats, guinea pigs, dogs and man. J Pharmacol Exp Ther. 1972 Feb;180(2):454–463. [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Neil-Dwyer G., Bartlett J., McAinsh J., Cruickshank J. M. Beta-adrenoceptor blockers and the blood-brian barrier. Br J Clin Pharmacol. 1981 Jun;11(6):549–553. doi: 10.1111/j.1365-2125.1981.tb01169.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Peet M., Middlemiss D. N., Yates R. A. Pharmacokinetic interaction between propranolol and chlorpromazine in schizophrenic patients. Lancet. 1980 Nov 1;2(8201):978–978. doi: 10.1016/s0140-6736(80)92135-2. [DOI] [PubMed] [Google Scholar]
- Topham J. C. Relationship between difference spectra and metabolism. Barbiturates, drug interaction and species difference. Biochem Pharmacol. 1970 May;19(5):1695–1701. doi: 10.1016/0006-2952(70)90160-7. [DOI] [PubMed] [Google Scholar]
- Woods P. B., Robinson M. L. An investigation of the comparative liposolubilities of beta-adrenoceptor blocking agents. J Pharm Pharmacol. 1981 Mar;33(3):172–173. doi: 10.1111/j.2042-7158.1981.tb13743.x. [DOI] [PubMed] [Google Scholar]